Alnylam and The Medicines Company collaborate on RNAi technology
With Angiomax potentially going generic in 2015, The Medicines Company has collaborated with Alnylam over a 'pragmatic' high cholesterol drug to aid future growth.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs